241 related articles for article (PubMed ID: 11841727)
1. SI-27, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity: detection with a variable-pressure scanning electron microscope.
Yoshida D; Noha M; Watanabe K; Sugisaki Y; Teramoto A
Neurosurgery; 2002 Mar; 50(3):578-86; discussion 586-8. PubMed ID: 11841727
[TBL] [Abstract][Full Text] [Related]
2. Novel approach to analysis of in vitro tumor angiogenesis with a variable-pressure scanning electron microscope: suppression by matrix metalloproteinase inhibitor SI-27.
Yoshida D; Noha M; Watanabe K; Sugisaki Y; Teramoto A
Brain Tumor Pathol; 2001; 18(2):89-100. PubMed ID: 11908879
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.
Wang H; Keiser JA
Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730
[TBL] [Abstract][Full Text] [Related]
4. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix.
Collen A; Hanemaaijer R; Lupu F; Quax PH; van Lent N; Grimbergen J; Peters E; Koolwijk P; van Hinsbergh VW
Blood; 2003 Mar; 101(5):1810-7. PubMed ID: 12393408
[TBL] [Abstract][Full Text] [Related]
5. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro.
Park HY; Kwon HM; Lim HJ; Hong BK; Lee JY; Park BE; Jang Y; Cho SY; Kim HS
Exp Mol Med; 2001 Jun; 33(2):95-102. PubMed ID: 11460888
[TBL] [Abstract][Full Text] [Related]
6. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2.
Qi JH; Ebrahem Q; Moore N; Murphy G; Claesson-Welsh L; Bond M; Baker A; Anand-Apte B
Nat Med; 2003 Apr; 9(4):407-15. PubMed ID: 12652295
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
Deryugina EI; Soroceanu L; Strongin AY
Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
[TBL] [Abstract][Full Text] [Related]
8. Suppression of matrix metalloproteinase activity by SI-27: detection by a new activity assay with S-2444, a specific chromogenic peptide.
Yoshida D; Watanabe K; Noha M; Takahashi H; Teramoto A
J Neurooncol; 2002 May; 58(1):1-11. PubMed ID: 12160135
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
10. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases.
Kim MH
J Cell Biochem; 2003 Jun; 89(3):529-38. PubMed ID: 12761886
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165.
Hashimoto G; Inoki I; Fujii Y; Aoki T; Ikeda E; Okada Y
J Biol Chem; 2002 Sep; 277(39):36288-95. PubMed ID: 12114504
[TBL] [Abstract][Full Text] [Related]
12. Monomethyl selenium--specific inhibition of MMP-2 and VEGF expression: implications for angiogenic switch regulation.
Jiang C; Ganther H; Lu J
Mol Carcinog; 2000 Dec; 29(4):236-50. PubMed ID: 11170262
[TBL] [Abstract][Full Text] [Related]
13. Suppression of cell invasion on human malignant glioma cell lines by a novel matrix-metalloproteinase inhibitor SI-27: in vitro study.
Noha M; Yoshida D; Watanabe K; Teramoto A
J Neurooncol; 2000 Jul; 48(3):217-23. PubMed ID: 11100819
[TBL] [Abstract][Full Text] [Related]
14. Suppression of human microvascular endothelial cell invasion and morphogenesis with synthetic matrixin inhibitors. Targeting angiogenesis with MMP inhibitors.
Jia MC; Schwartz MA; Sang QA
Adv Exp Med Biol; 2000; 476():181-94. PubMed ID: 10949665
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro.
Lamoreaux WJ; Fitzgerald ME; Reiner A; Hasty KA; Charles ST
Microvasc Res; 1998 Jan; 55(1):29-42. PubMed ID: 9473407
[TBL] [Abstract][Full Text] [Related]
16. MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells.
Huo N; Ichikawa Y; Kamiyama M; Ishikawa T; Hamaguchi Y; Hasegawa S; Nagashima Y; Miyazaki K; Shimada H
Cancer Lett; 2002 Mar; 177(1):95-100. PubMed ID: 11809536
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation.
Zucker S; Mirza H; Conner CE; Lorenz AF; Drews MH; Bahou WF; Jesty J
Int J Cancer; 1998 Mar; 75(5):780-6. PubMed ID: 9495249
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis.
Friehs I; Margossian RE; Moran AM; Cao-Danh H; Moses MA; del Nido PJ
Basic Res Cardiol; 2006 May; 101(3):204-13. PubMed ID: 16369727
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glioma angiogenesis and invasion by SI-27, an anti-matrix metalloproteinase agent in a rat brain tumor model.
Yoshida D; Takahashi H; Teramoto A
Neurosurgery; 2004 May; 54(5):1213-20; discussion 1220-1. PubMed ID: 15113477
[TBL] [Abstract][Full Text] [Related]
20. Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis.
Silvestre JS; Mallat Z; Tamarat R; Duriez M; Tedgui A; Levy BI
Circ Res; 2001 Aug; 89(3):259-64. PubMed ID: 11485976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
